| 6.—(1) For the purposes of these Regulations, an individual is treated as having a cleared status (general) only if he or she is and to the extent certified under this regulation as having a cleared status (general). [S 590/2021 wef 10/08/2021] [S 908/2021 wef 01/12/2021] (2) Where the Director or a recognised medical practitioner is satisfied that an individual is a recovered individual, the Director or recognised medical practitioner (as the case may be) may grant a certificate stating that the individual has a cleared status (general) for a period —| (a) | for a recovered individual who was never vaccinated against a COVID-19 infection before he or she was diagnosed as having the COVID‑19 infection —| (i) | starting the date the recovered individual first tested positive for SARS-CoV-2 upon undergoing a polymerase chain reaction test (whether before, on or after 24 April 2021); and | | (ii) | ending on (and including) as follows:| (A) | the 180th day after the date in sub-paragraph (i), unless sub-paragraph (B) applies; | | (B) | 31 January 2022, where the individual is a transitional case; or |
[S 991/2021 wef 01/01/2022] |
[S 590/2021 wef 10/08/2021] | | (b) | for a recovered individual who is diagnosed as having a COVID‑19 infection after a certificate under this paragraph had been granted in respect of the individual, and who was never vaccinated against a COVID‑19 infection, the period falling after the grant of the certificate —| (i) | starting the date the recovered individual first tested positive for SARS‑CoV‑2 upon undergoing a polymerase chain reaction test leading to the diagnosis of the individual having that infection; and | | (ii) | ending on (and including) as follows:| (A) | the 180th day after the date in sub-paragraph (i), unless sub-paragraph (B) applies; | | (B) | 31 January 2022, where the individual is a transitional case. |
[S 991/2021 wef 01/01/2022] |
[S 590/2021 wef 10/08/2021] |
|
(3) Where the Director is satisfied that —| (a) | an individual is a recovered individual; | | (b) | the individual is vaccinated against a COVID-19 infection by the administration of any approved vaccine by a recognised vaccination provider; and | | (c) | 14 days or more have elapsed after the day the individual was so vaccinated, |
| the Director may grant a certificate stating that an individual has a cleared status (general) for a period that starts and ends as stated opposite the approved vaccine in the First Schedule. |
|
(4) In addition, where the Director is satisfied that —| (a) | the individual (who is not a recovered individual) is vaccinated against a COVID‑19 infection by the administration of any approved vaccine by a recognised vaccination provider; and | | (b) | 14 days or more have elapsed after the day the individual was so vaccinated, |
| the Director may grant a certificate stating that an individual has a cleared status (general) for a period that starts and ends as stated opposite the approved vaccine in the First Schedule. |
|
(5) Despite paragraph (2), (3) or (4) and except where expressly provided in paragraph (5A), where an individual is diagnosed as having a COVID-19 infection, after he or she is —| (a) | vaccinated against the COVID-19 infection; and | | (b) | granted a certificate under paragraph (3) or (4), |
| then the Director or a recognised medical practitioner may, where satisfied that the individual is a recovered individual after that infection or any later infection, grant a certificate stating that the individual has a cleared status (general) for the period — |
| (c) | starting the date the recovered individual first tested positive for SARS-CoV-2 upon undergoing a polymerase chain reaction test leading to the diagnosis of the individual having the last infection he or she recovered from; and | | (d) | ending on (and including) —| (i) | the 180th day after the date in sub-paragraph (c); or [S 991/2021 wef 01/01/2022] | | (ii) | the day the period referred to in and applicable to the individual under paragraph (3) or (4) would have ended if the individual had not been diagnosed as having a COVID-19 infection, |
|
[S 590/2021 wef 10/08/2021] [S 991/2021 wef 01/01/2022] |
(5A) Where the Director is satisfied that an individual (of any age) —| (a) | has received (whether before, on or after 1 January 2022) one dose of any defined approved vaccine and one dose of any other approved vaccine, each administered to the individual at least 17 days apart regardless of sequence; | | (b) | subsequently tests positive for SARS-CoV-2 upon undergoing (whether before, on or after 1 January 2022) any of the following:| (i) | a polymerase chain reaction test in Singapore; | | (ii) | a polymerase chain reaction test outside Singapore, and a subsequent serology test in Singapore that is not attributable to the administration of any vaccine against a COVID-19 infection; |
| | (c) | is diagnosed (whether before, on or after 1 January 2022) as having had a COVID-19 infection; | | (d) | is no longer actively infected with a COVID-19 infection; and | | (e) | is without a cleared status (general), cleared status (special) or a cleared status (overseas temporary), |
| the Director may grant a certificate stating that the individual has a cleared status (general) for a period — |
| (f) | starting the date the recovered individual first tested positive for SARS-CoV-2 upon undergoing a polymerase chain reaction test mentioned in sub-paragraph (b) leading to the diagnosis of the individual having the last infection he or she recovered from; and | | (g) | ending on (and including) the 365th day after the date in sub-paragraph (f). |
[S 991/2021 wef 01/01/2022] |
(6) The Director may cancel any certificate granted under this regulation stating that an individual has a cleared status (general) if —| (a) | before the end of the period specified in paragraph (2), or referred to in paragraph (3), (4), (5) or (5A), as the case may be, and applicable to the individual —| (i) | the individual undergoes an approved test that is a polymerase chain reaction test; and | | (ii) | the individual’s test result shows the presence of SARS-CoV-2 in that individual and that is not an atypical finding for SARS-CoV-2; or |
[S 991/2021 wef 01/01/2022] | | (b) | the Director is satisfied that it is the interest of the health and safety of the individual to do so. |
[S 590/2021 wef 10/08/2021] |
| (7) To avoid doubt, the period in paragraph (3), (4) or (5) may be a period before 24 April 2021. [S 590/2021 wef 10/08/2021] |
(8) An individual is a transitional case for the purposes of paragraph (2) —| (a) | if he or she had acquired, before 1 January 2022, a cleared status (general) under paragraph (2), and would have continued on or after that date to have a cleared status (general) if not for the making of the Infectious Diseases (Mass Gathering Testing for Coronavirus Disease 2019) (Amendment No. 14) Regulations 2021; but | | (b) | not if he or she had acquired, before 1 January 2022, a cleared status (general) under paragraph (2) and ceased to have a cleared status (general) that is current before that date because of regulation 8A(1)(a) or (c). |
[S 991/2021 wef 01/01/2022] |
|